Chi‐Fei Huang

2.3k total citations
14 papers, 1.2k citations indexed

About

Chi‐Fei Huang is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Chi‐Fei Huang has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Chi‐Fei Huang's work include Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA modifications and cancer (3 papers). Chi‐Fei Huang is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and RNA modifications and cancer (3 papers). Chi‐Fei Huang collaborates with scholars based in Taiwan and United States. Chi‐Fei Huang's co-authors include Mei‐Hsuan Tseng, Jih‐Luh Tang, Chien‐Yuan Chen, Hwei‐Fang Tien, Ming Yao, Wen‐Chien Chou, Woei Tsay, Shang‐Ju Wu, Hsin‐An Hou and Shang‐Yi Huang and has published in prestigious journals such as Blood, Cancer Research and Journal of The Electrochemical Society.

In The Last Decade

Chi‐Fei Huang

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Fei Huang Taiwan 12 898 635 404 200 141 14 1.2k
Esperanza Such Spain 17 611 0.7× 508 0.8× 273 0.7× 113 0.6× 140 1.0× 61 988
Naomi Park United Kingdom 7 353 0.4× 373 0.6× 228 0.6× 184 0.9× 50 0.4× 11 761
HC Hoagland United States 8 538 0.6× 203 0.3× 245 0.6× 29 0.1× 152 1.1× 15 765
Timo Siitonen Finland 16 238 0.3× 229 0.4× 106 0.3× 36 0.2× 32 0.2× 48 572
Carlos Román Spain 15 177 0.2× 322 0.5× 98 0.2× 59 0.3× 52 0.4× 41 669
John Bognacki United States 12 273 0.3× 175 0.3× 90 0.2× 125 0.6× 34 0.2× 23 604
Yasushi Shimonaka United States 14 502 0.6× 196 0.3× 280 0.7× 34 0.2× 12 0.1× 31 772
Raquel Alves Portugal 13 179 0.2× 196 0.3× 111 0.3× 63 0.3× 25 0.2× 35 421
Yun Leng China 13 172 0.2× 433 0.7× 57 0.1× 110 0.6× 19 0.1× 48 655
Lan Lin China 15 229 0.3× 423 0.7× 33 0.1× 73 0.4× 138 1.0× 25 823

Countries citing papers authored by Chi‐Fei Huang

Since Specialization
Citations

This map shows the geographic impact of Chi‐Fei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Fei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Fei Huang more than expected).

Fields of papers citing papers by Chi‐Fei Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Fei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Fei Huang. The network helps show where Chi‐Fei Huang may publish in the future.

Co-authorship network of co-authors of Chi‐Fei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Fei Huang. A scholar is included among the top collaborators of Chi‐Fei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Fei Huang. Chi‐Fei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hsu, Mao‐Feng, et al.. (2021). Communication—Synthesis of Highly-Branched Silver Nanocrystals for EMI Shielding Applications. Journal of The Electrochemical Society. 168(1). 12505–12505. 2 indexed citations
2.
Lin, Chien‐Chin, Hsin‐An Hou, Wen‐Chien Chou, et al.. (2014). SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution. American Journal of Hematology. 89(8). E109–15. 27 indexed citations
3.
Wu, Shang‐Ju, Jih‐Luh Tang, Chien‐Ting Lin, et al.. (2013). Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression. American Journal of Hematology. 88(11). E277–82. 48 indexed citations
4.
Wu, Shang‐Ju, Yuan‐Yeh Kuo, Hsin‐An Hou, et al.. (2012). The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution. Blood. 120(15). 3106–3111. 109 indexed citations
5.
Chou, Wen‐Chien, Huai‐Hsuan Huang, Hsin‐An Hou, et al.. (2010). Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations. Blood. 116(20). 4086–4094. 163 indexed citations
6.
Hou, Hsin‐An, Tai‐Chung Huang, Liang‐In Lin, et al.. (2010). WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system. Blood. 115(25). 5222–5231. 111 indexed citations
7.
Chou, Wen‐Chien, Hsin‐An Hou, Chien‐Yuan Chen, et al.. (2010). Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation. Blood. 115(14). 2749–2754. 153 indexed citations
8.
Tang, Jih‐Luh, Liang‐In Lin, Chien‐Yuan Chen, et al.. (2009). AML1/RUNX1 Mutations in 470 Adult Patients with De Novo Acute Myeloid Leukemia: Prognostic Implication and Interaction with Other Gene Alterations.. Blood. 114(22). 1564–1564. 14 indexed citations
9.
Tang, Jih‐Luh, Hsin‐An Hou, Chien‐Yuan Chen, et al.. (2009). AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations. Blood. 114(26). 5352–5361. 240 indexed citations
10.
Hou, Hsin‐An, Wen‐Chien Chou, Liang‐In Lin, et al.. (2007). Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Leukemia Research. 32(6). 904–912. 47 indexed citations
11.
Yeung, Sin‐Yuet, Chi‐Fei Huang, Cheng-Chi Chan, et al.. (2007). Antioxidant and pro‐oxidant properties of chlorhexidine and its interaction with calcium hydroxide solutions. International Endodontic Journal. 40(11). 837–844. 47 indexed citations
12.
Hou, Hsin‐An, Wen‐Chien Chou, Chien‐Yuan Chen, et al.. (2007). Characterization of Acute Myeloid Leukemia with PTPN11 Mutation - The Mutation Is Closely Associated with NPM1 Mutation but Inversely Related to FLT3/ITD.. Blood. 110(11). 3490–3490. 4 indexed citations
13.
Chou, Wen‐Chien, Jih‐Luh Tang, Liang‐In Lin, et al.. (2006). Nucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease Evolution. Cancer Research. 66(6). 3310–3316. 115 indexed citations
14.
Yeung, Sin‐Yuet, W H Lan, Chi‐Fei Huang, et al.. (2002). Scavenging property of three cresol isomers against H2O2, hypochlorite, superoxide and hydroxyl radicals. Food and Chemical Toxicology. 40(10). 1403–1413. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026